Solara Active Pharma Sciences Ltd., incorporated in the year 2017, is a Small Cap company (having a market cap of Rs 6302.08 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 30-06-2021, the company reported a Consolidated Total Income of Rs 411.48 Crore, down -9.36 % from last quarter Total Income of Rs 453.99 Crore and up 16.57 % from last year same quarter Total Income of Rs 353.00 Crore. Company reported net profit after tax of Rs 50.11 Crore in latest quarter.
Investment Rationale
The brokerage remains positive on SOLARA as it is well-placed in the API space (product offering supported by manufacturing capacity/capability) to take advantage of the favorable demand scenario and building its presence across the CRAMS value chain.
Promoter/FII Holdings
Promoters held 41.1 per cent stake in the company as of June 30, 2021, while FIIs held 16.6 per cent, DIIs 6.4 per cent and public and others 35.9 per cent.
(Disclaimer: Views and recommendations given in this section are the analysts’ own and do not represent those of ETMarkets.com. Please consult your financial adviser before taking any position in the stock/s mentioned.
